Lv4
740 积分 2024-11-08 加入
TNIK in disease: from molecular insights to therapeutic prospects
6天前
已完结
Clearance in Drug Design
12天前
已完结
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19)
13天前
已完结
Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery
20天前
已完结
The glue degraders
1个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
1个月前
已完结
Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
1个月前
已完结
An updated review of small-molecule HPK1 kinase inhibitors (2016-present)
1个月前
已完结
Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer
1个月前
已完结
Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
1个月前
已完结
皖公网安备34019202002308
